Role of the Mitochondrial Signaling Pathway in Murine Coronavirus-induced Oligodendrocyte Apoptosis
Overview
Authors
Affiliations
A previous study demonstrated that infection of rat oligodendrocytes by mouse hepatitis virus (MHV) resulted in apoptosis, which is caspase dependent (Y. Liu, Y. Cai, and X. Zhang, J. Virol. 77:11952-11963, 2003). Here we determined the involvement of the mitochondrial pathway in MHV-induced oligodendrocyte apoptosis. We found that caspase-9 activity was 12-fold higher in virus-infected cells than in mock-infected cells at 24 h postinfection (p.i.). Pretreatment of cells with a caspase-9 inhibitor completely blocked caspase-9 activation and partially inhibited the apoptosis mediated by MHV infection. Analyses of cytochrome c release further revealed an activation of the mitochondrial apoptotic pathway. Stable overexpression of the two antiapoptotic proteins Bcl-2 and Bcl-xL significantly, though only partially, blocked apoptosis, suggesting that activation of the mitochondrial pathway is partially responsible for the apoptosis. To identify upstream signals, we determined caspase-8 activity, cleavage of Bid, and expression of Bax and Bad by Western blotting. We found a drastic increase in caspase-8 activity and cleavage of Bid at 24 h p.i. in virus-infected cells, suggesting that Bid may serve as a messenger to relay the signals from caspase-8 to mitochondria. However, treatment with a caspase-8 inhibitor only slightly blocked cytochrome c release from the mitochondria. Furthermore, we found that Bax but not Bad was significantly increased at 12 h p.i. in cells infected with both live and UV-inactivated viruses and that Bax activation was partially blocked by treatment with the caspase-8 inhibitor. These results thus establish the involvement of the mitochondrial pathway in MHV-induced oligodendrocyte apoptosis.
SARS-CoV-2 mitochondriopathy in COVID-19 pneumonia exacerbates hypoxemia.
Archer S, Dasgupta A, Chen K, Wu D, Baid K, Mamatis J Redox Biol. 2022; 58:102508.
PMID: 36334378 PMC: 9558649. DOI: 10.1016/j.redox.2022.102508.
Groppa S, Ciolac D, Duarte C, Garcia C, Gasnas D, Leahu P Adv Exp Med Biol. 2021; 1376:1-27.
PMID: 34735712 DOI: 10.1007/5584_2021_675.
Neuropathies and neurological dysfunction induced by coronaviruses.
Gholami M, Safari S, Ulloa L, Motaghinejad M J Neurovirol. 2021; 27(3):380-396.
PMID: 33983506 PMC: 8117458. DOI: 10.1007/s13365-021-00977-x.
Coronaviruses: Innate Immunity, Inflammasome Activation, Inflammatory Cell Death, and Cytokines.
Lee S, Channappanavar R, Kanneganti T Trends Immunol. 2020; 41(12):1083-1099.
PMID: 33153908 PMC: 7561287. DOI: 10.1016/j.it.2020.10.005.
Neurobiology of coronaviruses: Potential relevance for COVID-19.
Cataldi M, Pignataro G, Taglialatela M Neurobiol Dis. 2020; 143:105007.
PMID: 32622086 PMC: 7329662. DOI: 10.1016/j.nbd.2020.105007.